News
May 20, 2021
Life Molecular Imaging Receives Orphan Drug Designations for its Tau Tracer PI-2620 as Diagnostic Tool for Progressive Supranuclear Palsy and Corticobasal Degeneration
Read more
March 3, 2021
Life Molecular Imaging announces an ongoing collaboration with UCB for PI-2620, a novel tau imaging agent, for improved diagnosis of Progressive Supranuclear Palsy
Read more
December 11, 2020
Life Molecular Imaging is Proud to Support the New IDEAS Study to Further Demonstrate the Value of Amyloid PET for Diagnosing Alzheimer’s Disease in Diverse Communities
Read more
July 07, 2020
Life Molecular Imaging and AC Immune announce the publication of clinical data of the investigational Tau-PET tracer PI-2620 in patients with progressive supranuclear palsy (PSP)
Read more
January 15, 2020
Life Molecular Imaging announces presentation of new scientific data at the Human Amyloid Imaging Meeting in Miami
Read more
November 11, 2019
Life Molecular Imaging and ITELPHARMA Announce a Strategic Partnership for Supply and Future Production of NeuraCeqTM in Italy
Read more
October 14, 2019
Life Molecular Imaging and Positron Pharma Announce a Strategic Partnership for Manufacturing and Distribution of PI-2620 in Chile
Read more
October 13, 2019
Life Molecular Imaging announces presentation of new research results at the European Association of Nuclear Medicine 2019 Annual Meeting
Read more
October 3, 2019
Job offer: Key Account Manager (m/f/d)
Read more
September 17, 2019
Life Molecular Imaging started recruitment for longitudinal Phase 2 Study with the Tau tracer PI-2620
Read more
July 9, 2019
DuChemBio Co. Ltd. and Life Molecular Imaging SA sign a Manufacturing and Supply Agreement for Alzheimer’s Disease Diagnostic Radiopharmaceutical for The Philippines
Read more
June 14, 2019
Life Molecular Imaging and National Cyclotron and PET Centre, Chulabhorn Royal Academy, Thailand Announce a Collaboration for Brain PET Imaging with NeuraCeq and PI-2620
Read more
April 27, 2019
Life Molecular Imaging and Institut de Radiofarmàcia Aplicada de Barcelona (IRAB) Announce a Strategic Partnership for Production of NeuraCeq and PI-2620 in Barcelona
Read more
April 8, 2019
Life Molecular Imaging Applauds the Publication of the IDEAS Study Aim I Results
Read more
March 27, 2019
Life Molecular Imaging Announces Presentation of New Clinical Data of the Next Generation Tau PET Tracer PI-2620 at the AD/PD 2019 Conference
Read more
October 26, 2018
Life Molecular Imaging and XingImaging Announce PI-2620 Tau PET Tracer Production in Mainland China
Read more
September 13, 2018
Life Molecular Imaging and SOFIE announce PI-2620 Tau PET Tracer Production in SOFIE Radiopharmacy Network
Read more
August 27, 2018
Piramal Imaging becomes Life Molecular Imaging
Read more
June 26, 2018
Alliance Medical completes the purchase of Piramal Imaging.
Read more
May 11, 2018
Piramal Imaging SA and SWAN Isotopen AG Announce Regulatory Approval of Neuraceq™ in Switzerland and Market Launch
Read more
March 27, 2018
Piramal Imaging Announces Strategic Partnership with PositronPharma for Manufacturing and Distribution of Neuraceq™ in Chile
Read more
January 17, 2018
New Research with Piramal Imaging’s Compounds Presented at Human Amyloid Imaging Annual Meeting
Read more